Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Documented comorbidities like hypertension, type 2 diabetes, or sleep apnea significantly improve approval odds
With a shelf life of 18 months, each batch is manufactured, supplied, and serviced across India to meet a range of packaging size requirements
Shipping & Processing
View Study [3]"Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity" Garvey WT et al., 2025 Finding: The REDEFINE 1 Phase 3 trial showed CagriSema achieved 20.4% weight loss versus 3% with placebo over 68 weeks in 3,417 participants
Rankings reflect our editorial assessment and are not influenced by paid placements
US$ 25.13
US$ 22.98
US$ 25.31
US$ 21.11
US$ 22.97
